Understanding prostate cancer screening barriers in Black men in faith communities
The Effect of the Prostate Cancer Foundation Screening Guidelines for Black Men on Intention to Screen in Faith-based Communities
M.D. Anderson Cancer Center · NCT06838325
This study looks at the reasons why Black men in faith communities might not get screened for prostate cancer to help create better education and support for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 24 (estimated) |
| Ages | 40 Years to 75 Years |
| Sex | Male |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06838325 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify barriers to prostate cancer screening among Black men in faith-based communities. Through focus group assessments, the study will gather insights that will inform the development of a culturally relevant prostate cancer education and early detection program. The goal is to enhance awareness and encourage screening within these communities, ultimately aiming to improve health outcomes for Black men at risk for prostate cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are Black or African American men who are willing to participate and provide informed consent.
Not a fit: Patients who are non-English proficient or unwilling to participate in the study will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to increased prostate cancer screening rates and better health outcomes for Black men.
How similar studies have performed: Other studies have shown success in addressing health disparities through culturally tailored interventions, suggesting a promising approach for this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-reported identification of Black/ African American * Willingness to participate in the study with signed and dated informed consent Exclusion Criteria: * Non-english proficiency * Unwillingness to participate in the study or inability to sign and date an informed consent
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Matthew T Smith — M.D. Anderson Cancer Center
- Study coordinator: Matthew T Smith
- Email: mtsmith2@mdanderson.org
- Phone: 713-606-2061
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prostate Cancer Screening